The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cisplatin and capecitabine as definitive chemoradiation for squamous cell carcinoma of the anal canal (SCCAC): A prospective cohort.
 
Abraão Dornellas
Speakers' Bureau - Adium Pharma; AstraZeneca; Bayer; BMS Brazil; Daiichi Sankyo; Gilead Sciences; Ipsen; Janssen; Libbs; Lilly; Merck; MSD; Novartis; Pfizer; Roche; SERVIER
Travel, Accommodations, Expenses - AstraZeneca
 
Renata Colombo Bonadio
Consulting or Advisory Role - MSD
Speakers' Bureau - Adium Pharma; AstraZeneca; BMS Brazil; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; MSD; Nestle health science; Pfizer
Research Funding - AstraZeneca (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Daiichi Sankyo/Astra Zeneca; MSD; MSD
 
Priscila Muniz Moraes
No Relationships to Disclose
 
Denis Galhera
No Relationships to Disclose
 
Carolina Ribeiro Victor
No Relationships to Disclose
 
Andre Tsin Chih Chen
No Relationships to Disclose
 
Carolina Teixeira Muratori
No Relationships to Disclose
 
Cinthia Ortega
Honoraria - Johnson & Johnson/Janssen
 
Henrique Souza Alves
No Relationships to Disclose
 
Karim Ibrahim
No Relationships to Disclose
 
Caio Nahas
No Relationships to Disclose
 
Carlos Frederico Marques
No Relationships to Disclose
 
Luciana Bastos Valente Alban
No Relationships to Disclose
 
Maria Ignez Braghiroli
Honoraria - Amgen; Bayer; BMS Brazil; Eurofarma; MSD; Takeda
Consulting or Advisory Role - AstraZeneca; BeiGene; Johnson & Johnson/MedTech; Lilly; Merck; MSD; Roche; SERVIER; SERVIER
Research Funding - AstraZeneca (Inst); BeiGene (Inst); Bristol-Myers Squibb Brazil (Inst); Daiichi Sankyo/Astra Zeneca (Inst); MSD (Inst)
Travel, Accommodations, Expenses - Bayer; BMS Brazil; MSD; SERVIER
 
Paulo Marcelo Hoff
Leadership - Oncologia D’Or
Stock and Other Ownership Interests - Oncostar
Honoraria - Bayer Health (I); United medical (I)
Consulting or Advisory Role - AstraZeneca (Inst); Bayer (I); EMS; Exelixis (I); Lilly (I); United Health Group (I)
Research Funding - AstraZeneca/MedImmune (Inst); Bayer (Inst); BMS Brazil (Inst); Exelixis (Inst); Lilly (I); MSD Oncology (Inst); Novartis (Inst); Roche/Genentech (Inst)
(OPTIONAL) Uncompensated Relationships - AstraZeneca
 
Camila M Venchiarutti Moniz
Honoraria - Libbs
Research Funding - BMS; Immix BioPharma; Jazz Pharmaceuticals; Merck; Servier/Pfizer; Takeda
Travel, Accommodations, Expenses - Libbs; Merck